News
Akcea's rare disease drug Waylivra way too pricey for NHS, s...
Less than a week into 2020 and NICE has provisionally ruled against NHS funding for another drug – in this case Akcea’s ground-breaking antisense drug Waylivra (volanesorsen) for the ultra-
